Quick Answer
CORCEPT THERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $120.50 million for the year ending 2025.
- CORCEPT THERAPEUTICS INC showed a decrease of -5.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), CORCEPT THERAPEUTICS INC's Cash And Cash Equivalents At Carrying Value has grown by 718.8%.
- Historical annual values: Fiscal year 2025: $120.50 million | Fiscal year 2024: $127.67 million | Fiscal year 2023: $135.55 million | Fiscal year 2022: $66.33 million | Fiscal year 2021: $77.62 million | Fiscal year 2020: $76.19 million | Fiscal year 2019: $31.27 million | Fiscal year 2018: $41.63 million | Fiscal year 2017: $31.06 million | Fiscal year 2016: $51.54 million | Fiscal year 2015: $40.44 million | Fiscal year 2014: $24.25 million | Fiscal year 2013: $54.88 million | Fiscal year 2012: $93.03 million | Fiscal year 2011: $39.64 million | Fiscal year 2010: $24.58 million | Fiscal year 2009: $23.87 million | Fiscal year 2008: $14.72 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: